Improvement of attention deficit/hyperactivity disorder (ADHD) in three adult men during testosterone treatment: a case series
- PMID: 36397172
- PMCID: PMC9673294
- DOI: 10.1186/s13256-022-03651-w
Improvement of attention deficit/hyperactivity disorder (ADHD) in three adult men during testosterone treatment: a case series
Abstract
Background: Attention deficit/hyperactivity disorder (ADHD) entails inattention, impulsivity, and restlessness at a disabling level. The pharmacological treatment of ADHD rests on the use of centrally acting stimulants, such as methylphenidate and D-amphetamine. In some patients, these drugs cause side effects that preclude their use.
Case presentation: We present three adult male, Caucasian, ADHD patients (24, 37, and 43 years old) whose ADHD symptoms improved during treatment with testosterone. The first patient experienced loss of libido during treatment with methylphenidate; for this, he was offered a trial of testosterone. Unexpectedly, his ADHD symptoms improved with testosterone treatment, and this effect continued with testosterone as monotherapy. The two other patients, who also had side effects from centrally acting stimulants, received testosterone monotherapy with similar results. The effect has now continued for 4.5-5 years at the same doses: 10-60 mg testosterone/day, administered as a skin gel. Prior to testosterone treatment, the patients had serum levels of testosterone in the low-normal range: 12-16 nmol/L (age-specific reference range: 10.4-32.6 nmol/L). The testosterone/sex hormone-binding globulin ratio was low in two patients (0.32 and 0.34; age-specific reference range: 0.38-1.1), suggesting low free serum levels of testosterone. Serum testosterone levels and testosterone/sex hormone-binding globulin ratios increased with testosterone treatment in all patients, but remained within reference values.
Conclusion: These cases suggest that a moderately reduced serum level of free testosterone may contribute to the ADHD symptoms of some adult male ADHD patients, and that testosterone treatment may be of value for these patients.
Keywords: ADHD; Attention deficit/hyperactivity disorder; Case report; Impulsivity; Inattention; Sex hormone-binding globulin; Side effects; Testosterone treatment.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that the work was conducted in the absence of any commercial or financial relationships that could be understood as a potential conflict of interest.
Similar articles
-
Mullerian inhibiting substance, sex hormone binding globulin and sex hormone levels in stimulant-naïve, first-diagnosed prepubertal boys with attention-deficit/hyperactivity disorder: comparison with matched healthy controls as well as before and after oros-methylpenidate treatment.Int J Psychiatry Clin Pract. 2019 Nov;23(4):251-257. doi: 10.1080/13651501.2019.1602657. Epub 2019 Jul 24. Int J Psychiatry Clin Pract. 2019. PMID: 31339400
-
Potential disturbance of methylphenidate of gonadal hormones or pubescent development in patients with attention-deficit/hyperactivity disorder: A twelve-month follow-up study.Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jun 8;108:110181. doi: 10.1016/j.pnpbp.2020.110181. Epub 2020 Nov 21. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 33227299
-
Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.Cochrane Database Syst Rev. 2021 Jan 18;1(1):CD013011. doi: 10.1002/14651858.CD013011.pub2. Cochrane Database Syst Rev. 2021. PMID: 33460048 Free PMC article.
-
Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.J Child Psychol Psychiatry. 2021 Jun;62(6):680-700. doi: 10.1111/jcpp.13305. Epub 2020 Aug 26. J Child Psychol Psychiatry. 2021. PMID: 32845025
-
Efficacy of osmotic-release oral system (OROS) methylphenidate for mothers with attention-deficit/hyperactivity disorder (ADHD): preliminary report of effects on ADHD symptoms and parenting.J Clin Psychiatry. 2008 Dec;69(12):1938-47. doi: 10.4088/jcp.v69n1213. Epub 2008 Dec 2. J Clin Psychiatry. 2008. PMID: 19192455 Clinical Trial.
Cited by
-
Evaluating the impact of testosterone replacement therapy on carotid atherosclerosis: a systematic review and meta-analysis.Future Sci OA. 2024 Dec 31;10(1):2365125. doi: 10.1080/20565623.2024.2365125. Epub 2024 Aug 25. Future Sci OA. 2024. PMID: 39183456 Free PMC article. Review.
-
ADHD and Sex Hormones in Females: A Systematic Review.J Atten Disord. 2025 Jul;29(9):706-723. doi: 10.1177/10870547251332319. Epub 2025 Apr 18. J Atten Disord. 2025. PMID: 40251875 Free PMC article.
-
The Impact of Methylphenidate on Sexual Functions: A Systematic Review of Benefits and Risks.Pharmaceuticals (Basel). 2025 May 14;18(5):718. doi: 10.3390/ph18050718. Pharmaceuticals (Basel). 2025. PMID: 40430537 Free PMC article. Review.
References
-
- American Psychiatry Association . Diagnostic and Statistical Manual of Mental Disorders (Fifth edition) Washington: American Psychiatry Publishing; 2013.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical